Cargando…

Respiratory Review of 2014: Asthma

Asthma is a chronic inflammatory disease of the airway that comprises a variety of etiologies and inflammatory phenotypes. Clinically, there is a wide range of patients with varying severities and responses to individual drugs. The introduction of inhaled corticosteroid therapy has dramatically chan...

Descripción completa

Detalles Bibliográficos
Autor principal: Yoon, Ho Il
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286780/
https://www.ncbi.nlm.nih.gov/pubmed/25580139
http://dx.doi.org/10.4046/trd.2014.77.6.237
_version_ 1782351705052020736
author Yoon, Ho Il
author_facet Yoon, Ho Il
author_sort Yoon, Ho Il
collection PubMed
description Asthma is a chronic inflammatory disease of the airway that comprises a variety of etiologies and inflammatory phenotypes. Clinically, there is a wide range of patients with varying severities and responses to individual drugs. The introduction of inhaled corticosteroid therapy has dramatically changed the treatment of asthma. Recent development of new therapies suggests the possibility of another breakthrough. These can be categorized as follows: anti-cytokine therapies that usually target eosinophilic inflammation, sublingual immunotherapy, and bronchial thermoplasty. In this paper, we will review the major articles related to asthma treatment that were published in 2013.
format Online
Article
Text
id pubmed-4286780
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher The Korean Academy of Tuberculosis and Respiratory Diseases
record_format MEDLINE/PubMed
spelling pubmed-42867802015-01-11 Respiratory Review of 2014: Asthma Yoon, Ho Il Tuberc Respir Dis (Seoul) Review Asthma is a chronic inflammatory disease of the airway that comprises a variety of etiologies and inflammatory phenotypes. Clinically, there is a wide range of patients with varying severities and responses to individual drugs. The introduction of inhaled corticosteroid therapy has dramatically changed the treatment of asthma. Recent development of new therapies suggests the possibility of another breakthrough. These can be categorized as follows: anti-cytokine therapies that usually target eosinophilic inflammation, sublingual immunotherapy, and bronchial thermoplasty. In this paper, we will review the major articles related to asthma treatment that were published in 2013. The Korean Academy of Tuberculosis and Respiratory Diseases 2014-12 2014-12-31 /pmc/articles/PMC4286780/ /pubmed/25580139 http://dx.doi.org/10.4046/trd.2014.77.6.237 Text en Copyright©2014. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved. http://creativecommons.org/licenses/by-nc/3.0/ It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)
spellingShingle Review
Yoon, Ho Il
Respiratory Review of 2014: Asthma
title Respiratory Review of 2014: Asthma
title_full Respiratory Review of 2014: Asthma
title_fullStr Respiratory Review of 2014: Asthma
title_full_unstemmed Respiratory Review of 2014: Asthma
title_short Respiratory Review of 2014: Asthma
title_sort respiratory review of 2014: asthma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286780/
https://www.ncbi.nlm.nih.gov/pubmed/25580139
http://dx.doi.org/10.4046/trd.2014.77.6.237
work_keys_str_mv AT yoonhoil respiratoryreviewof2014asthma